Articles by Gautam T. Jayram, MD
Dr. Jayram highlights the updates in the ADVANCED-2 study: TARA-002 for patients with high-grade NMIBC.
Dr. Jayram breaks down important topics in kidney cancer from LUGPA 2024, including adjuvant pembrolizumab post-nephrectomy.
Dr. Jayram provides insights into the BCG-unresponsive and BCG-naive bladder cancer space at the LUGPA 2024 Annual Meeting.
The panelists consider patient expectations, considerations, and how they handle setting those expectations.
The panelists compare what they describe as apples and oranges.
The fourth part of this series focuses on the past and future landscape of clinical trials and logistic considerations.
Panelists discuss the data pipeline from clinical trials to the community setting in the third part of this series on NMIBC.
The second part of this roundtable series on NMIBC explores the relevant and current clinical trials.
The first part of six roundtable sessions on treatment advancements in NMIBC.
Dr. Gautam Jayram discusses his biggest takeaways from the event, including panels on non-muscle invasive bladder cancer.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.